SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Paramount Skydance Corp. is a next-generation global media and entertainment company that engages in providing content creation and distribution services. It operates through the following business segments: Studios, Direct-to-Consumer, and TV Media. Its portfolio unites brands including Paramount Pictures, Paramount Television, CBS, CBS News, Nickelodeon, MTV, BET, Comedy Central, Showtime, Paramount Plus, Pluto TV, and Skydance’s Animation, Film, Television, Interactive/Games, and Sports divisions. The company was founded on June 3, 2024 and is headquartered in New York, NY.

Paramount Skydance Corp. - Ordinary Shares - Class B

Paramount Skydance is garnering significant attention as its exclusive UFC streaming debut on Paramount+ drives widespread community enthusiasm and propels the app to top charts. This strong performance provides a backdrop to the ongoing competitive pursuit of Warner Bros. Discovery, where the company's fully financed bid is challenging a rival offer amidst discussions around regulatory approvals and true asset valuation.

United States Antimony Corp. engages in the extraction, processing and sale of antimony, zeolite, silver, and gold products. It operates through the following segments: United States Antimony Operations, Mexican Antimony Operations, Precious Metals Recovery, and United States Zeolite Operations. The company was founded by John C. Lawrence in June 1968 and is headquartered in Thompson Falls, MT.

United States Antimony Corp.

United States Antimony Corp

United States Antimony Corp. is trending as it strengthens its position as a fully integrated antimony producer with a recent facility acquisition. The community is actively discussing the company's critical role in U.S. defense, anticipating significant government investment or strategic partnerships. This comes amidst a broader sector rally driven by geopolitical demand for rare earths and growing institutional interest.

Brand Engagement Network, Inc. engages in the provision of conversational artificial intelligence assistants with the purpose of transforming engagement and analytics for businesses through security-focused, multimodal communication and human-like artificial intelligence assistants. The firm is also involved in delivering highly personalized, multi-modal artificial intelligence engagement with a focus on industries where there is a massive workforce gap and an opportunity to transform how consumers engage with networks, providers, and brands. The company is founded on March 14, 2024 and is headquartered in Jackson, WY.

Brand Engagement Network Inc

Brand Engagement Network Inc. (BNAI) is experiencing a massive surge driven by an extreme short squeeze, fueled by its exceptionally low public float and recent reverse stock split. The community is actively discussing significant parabolic gains and drawing comparisons to past high-volatility meme stocks, with strong FOMO present alongside warnings of extreme speculation. This intense retail interest is amplified by the company's position within the broader AI sector.

USA Rare Earth, Inc. is domestic supplier of rare earth magnets and heavy rare earth elements. It is developing a vertically integrated, domestic supply chain for rare earth element magnet production, with a facility in Stillwater, Oklahoma, and mining rights to the Round Top heavy rare earth and critical minerals deposit in West Texas. The company was founded in May 2019 and is headquartered in Stillwater, OK.

USA Rare Earth Inc. - Ordinary Shares - Class A

USA Rare Earth Inc

USA Rare Earth (USAR) is experiencing significant attention following reports of a substantial $1.6 billion government investment, including an equity stake and debt financing, aimed at bolstering domestic critical mineral production for national security. The community is actively discussing the deal's potential to drive a major revaluation of the company, with many anticipating substantial price appreciation and positive ripple effects across the broader rare earth sector.

Redwire Corp. manufactures and supplies space equipment. It offers critical space solutions and reliability components for the next generation space economy with IP for solar power generation and in-space 3D printing and manufacturing. It assists its customers in solving challenges of future space missions. The company was founded in 2020 and is headquartered in Jacksonville, FL.

Redwire Corporation

Redwire Corp

Redwire is currently trending amidst widespread community discussion about its potential integral role in the "Golden Dome" national missile defense initiative and increasing contracts across the defense and space sectors. Investors are particularly optimistic about its diverse capabilities, including advanced space infrastructure, in-space manufacturing, and its strategic position in rapidly expanding areas like space healthcare and national security.

$Goldcoin: the gold standard on Solana. All PumpFun CTO Creator Rewards are allocated 50% for buybacks &amp; burns and 50% for marketing + development daily. Full transparent CTO leadership providing on-chain + social proof evidence of all transactions. We provide provide daily Token Improvement Reports that highlight all the reward claims, allocations, showing 50% buyback and burn transactions, and all marketing expense transactions for $Goldcoin every day.  Community CTO involved in voting and decision-making as often as possible.

goldcoin

GOLDCOIN CRYPTO is trending with significant bullish momentum, fueled by its notably low market cap and a deflationary tokenomics model featuring daily burns. The community is actively discussing its potential as a "digital gold" on Solana, buoyed by recent developments including a game launch and an upcoming AMA, making it a focal point during the current crypto market rotation.

Greenwich LifeSciences, Inc. engages in the development of a breast cancer immunotherapy designed to prevent the recurrence of breast cancer following surgery. The company was founded by Eric Rothe on August 29, 2006 and is headquartered in Stafford, TX.

Greenwich LifeSciences Inc

Greenwich LifeSciences is trending following FDA approval for the commercial manufacturing of its GP2 drug for the FLAMINGO-01 trial, a key milestone de-risking its path toward a Biologics License Application. The community is highly engaged, emphasizing the drug's potential for breast cancer recurrence prevention, continuous insider buying by the CEO, and the potential for a significant short squeeze due to the stock's exceptionally low float. Many investors are actively accumulating shares, anticipating further strategic announcements or a partnership.

ProShares Trust - ProShares UltraShort Bloomberg Natural Gas -2x Shares

ProShares UltraShort Bloomberg Natural Gas

ProShares UltraShort Bloomberg Natural Gas (KOLD) is experiencing intense trading as a deep freeze grips parts of the US, sparking a fierce debate among investors. While extreme cold initially fueled a surge in natural gas prices, many in the community now anticipate a significant pullback, viewing the weather impact as over-hyped and temporary. Traders are actively discussing accumulating KOLD, betting on warmer forecasts and minimal production disruptions to drive a reversal in the volatile natural gas market.

Rigetti Computing, Inc. provides full-stack quantum computing services. It serves global enterprise, government, and research clients through its Rigetti Quantum Cloud Services platform. The company was founded by Chad Rigetti in 2013 and is headquartered in Berkeley, CA.

Rigetti Computing Inc

Rigetti Computing is trending due to a new $8.4 million order for its 108-qubit quantum computer from India, alongside recent analyst upgrades to "Buy" with price targets up to $40. This news has sparked a heated debate among investors, with optimists pointing to quantum computing's long-term potential and short squeeze catalysts, while skeptics express concern over the company's high valuation, delayed product milestones, and ongoing insider selling.

Jazz Pharmaceuticals Plc operates as a biopharmaceutical company, which focuses on the identification, development, and commercialization of pharmaceutical products in the areas of narcolepsy, oncology, pain, and psychiatry. Its product portfolio includes: Xyrem, Xywav, Epidolex, Zepzelca, Rylaze, Vyxeos, and Defitelio. The company was founded by Bruce C. Cozadd in March 2003 and is headquartered in Dublin, Ireland.

Jazz Pharmaceuticals plc

Jazz Pharmaceuticals is currently trending following overwhelmingly positive Phase 3 clinical trial data for its cancer drug, Ziihera (zanidatamab), in HER2-positive gastroesophageal cancer and its recent accelerated FDA approval for biliary tract cancer. The community is actively discussing these results as a potential "game-changer" and a "monster in the making," speculating on Ziihera becoming a new standard of care and even hinting at potential buyout interest for the company.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Rigel Pharmaceuticals (NASDAQ:RIGL) Downgraded to "Strong Sell" Rating by Zacks Research

Zacks Research lowered shares of Rigel Pharmaceuticals from a "strong-buy" rating to a "strong sell" rating in a report on Tuesday...

Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Sees Significant Growth in Short Interest

Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL - Get Free Report) was the recipient of a large growth in short interest in December. As of December 31st, there was short interest totaling 3,439,339 shares...

Profound Medical (PROF) Soars 9.5%: Is Further Upside Left in the Stock?

Profound Medical (PROF) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

HC Wainwright Has Negative Forecast for RIGL FY2026 Earnings

Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL - Free Report) - Analysts at HC Wainwright lowered their FY2026 earnings per share estimates for Rigel Pharmaceuticals in a research report issued to clients...

Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Given Consensus Rating of "Moderate Buy" by Analysts

Shares of Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL - Get Free Report) have received a consensus recommendation of "Moderate Buy" from the seven research firms that are currently covering the stock...

Rigel Provides Business Update and 2026 Outlook

Rigel Provides Business Update and 2026 Outlook Rigel Provides Business Update and 2026 Outlook PR Newswire SOUTH SAN FRANCISCO, Calif., Jan. 12, 2026 Preliminary fourth quarter 2025 total revenue of...

CNC Deepens Medicaid Strategy With Cityblock Partnership in Illinois

Centene expands its Medicaid strategy by partnering with Cityblock Health to serve 10,000 Illinois members with 24/7 wrap-around care.

Zacks Industry Outlook Highlights Soleno Therapeutics, Nektar Therapeutics, Rigel Pharmaceuticals, Ironwood Pharmaceuticals and Marker Therapeutics

Soleno Therapeutics leads a rebound in small drug stocks as innovation, pipeline progress and M&A activity fuel optimism for 2026.

Select Medical Expands Rehab Footprint Through Vibra Healthcare JV

SEM teams up with Vibra Healthcare to run a 76-bed rehab hospital in Southern Kentucky, expanding its post-acute care footprint through a capital-efficient JV.

5 Small Drug Stocks to Buy as Industry Recovery Picks Up

Innovation is at its peak in the Zacks Medical-Drugs industry. SLNO, NKTR, RIGL, IRWD and MRKR may prove to be good additions to one's portfolio.

Rigel Pharmaceuticals, Inc. operates as a clinical stage biotechnology company. It discovers and develops novel, targeted drugs in the therapeutic areas of immunology, oncology and immune oncology. The firm focuses on intracellular signalling pathways and related targets that are critical to disease mechanisms. The company's products include Tavalisse, Fostamatinib and R835. Rigel Pharmaceuticals was founded by Donald G. Payan, James M. Gower, Thomas A. Raffin, Garry P. Nolan and Ronald B. Garren on June 14, 1996 and is headquartered in South San Francisco, CA.

Rigel Pharmaceuticals

$MSFT

$AAPL

$TSLA

$META

Earnings season is heating up, and several major companies report next week, including Microsoft, Apple, Tesla, and Meta. Which are you most excited for?

Which earnings report are you most excited for next week? 
 
Drop a comment for others.

RIGL
Rigel Pharmaceuticals

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest RIGL News

RIGLRigel Pharmaceuticals